Previous 10 | Next 10 |
home / stock / tlt:cc / tlt:cc news
TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“ Theralase® ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company focused on the research and development of light activated Phot...
TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“ Theralase® ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company focused on the research and development of light activated Phot...
TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Theralase ® Technologies Inc. (“ Theralase ” or “ Company ”) ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynami...
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC , Jan. 5, 2023 /CNW/ - TSX VENTURE COMPANIES ALPINE SUMMIT ENERGY PARTNERS, INC. ("ALPS.U ") BULLETIN TYPE: Declaration of Dividend BULLETIN DAT...
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“ Theralase ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light activated Ph...
TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“ Theralase® ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company focused on the research and development of light activate...
TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“ Theralase® ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company focused on the research and development of light activate...
Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Theralase ® Technologies Inc. (“ Theralase ® ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: T...
TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Theralase ® Technologies Inc. (“ Theralase ” or “ Company ”) ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company focused on the research and development of light activated Photo...
TORONTO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Theralase ® Technologies Inc. (“ Theralase ® ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company focused on the research and development of lig...
News, Short Squeeze, Breakout and More Instantly...
Theralase Technologies Inc. Company Name:
TLT:CC Stock Symbol:
TSXVC Market:
Theralase Technologies Inc. Website:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...